Literature DB >> 20924653

In vivo methods to study uptake of nanoparticles into the brain.

Inge van Rooy1, Serpil Cakir-Tascioglu, Wim E Hennink, Gert Storm, Raymond M Schiffelers, Enrico Mastrobattista.   

Abstract

Several in vivo techniques have been developed to study and measure the uptake of CNS compounds into the brain. With these techniques, various parameters can be determined after drug administration, including the blood-to-brain influx constant (K(in)), the permeability-surface area (PS) product, and the brain uptake index (BUI). These techniques have been mostly used for drugs that are expected to enter the brain via transmembrane diffusion or by carrier-mediated transcytosis. Drugs that have limitations in entering the brain via such pathways have been encapsulated in nanoparticles (based on lipids or synthetic polymers) to enhance brain uptake. Nanoparticles are different from CNS compounds in size, composition and uptake mechanisms. This has led to different methods and approaches to study brain uptake in vivo. Here we discuss the techniques generally used to measure nanoparticle uptake in addition to the techniques used for CNS compounds. Techniques include visualization methods, behavioral tests, and quantitative methods.

Entities:  

Mesh:

Year:  2010        PMID: 20924653      PMCID: PMC3044085          DOI: 10.1007/s11095-010-0291-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  97 in total

1.  Small-animal molecular imaging methods.

Authors:  Robert A de Kemp; Frederick H Epstein; Ciprian Catana; Benjamin M W Tsui; Erik L Ritman
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.

Authors:  Luca Costantino; Francesca Gandolfi; Giovanni Tosi; Francesco Rivasi; Maria Angela Vandelli; Flavio Forni
Journal:  J Control Release       Date:  2005-09-08       Impact factor: 9.776

Review 3.  Assays to predict drug permeation across the blood-brain barrier, and distribution to brain.

Authors:  N J Abbott; D E M Dolman; A K Patabendige
Journal:  Curr Drug Metab       Date:  2008-11       Impact factor: 3.731

4.  Brain-specific expression of an exogenous gene after i.v. administration.

Authors:  N Shi; Y Zhang; C Zhu; R J Boado; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers.

Authors:  Praneet Opanasopit; Megumi Sakai; Makiya Nishikawa; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

6.  Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis.

Authors:  Janine Doorduin; Hans C Klein; Johan R de Jong; Rudi A Dierckx; Erik F J de Vries
Journal:  Nucl Med Biol       Date:  2009-10-22       Impact factor: 2.408

7.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

Authors:  Anja Zensi; David Begley; Charles Pontikis; Celine Legros; Larisa Mihoreanu; Sylvia Wagner; Claudia Büchel; Hagen von Briesen; Jörg Kreuter
Journal:  J Control Release       Date:  2009-03-11       Impact factor: 9.776

8.  Triglycerides induce leptin resistance at the blood-brain barrier.

Authors:  William A Banks; Alan B Coon; Sandra M Robinson; Asif Moinuddin; Jessica M Shultz; Ryota Nakaoke; John E Morley
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

9.  Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.

Authors:  A Régina; M Demeule; C Ché; I Lavallée; J Poirier; R Gabathuler; R Béliveau; J-P Castaigne
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

Review 10.  Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.

Authors:  William A Banks
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more
  27 in total

Review 1.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

2.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

3.  Intranasal instillation of iron oxide nanoparticles induces inflammation and perturbation of trace elements and neurotransmitters, but not behavioral impairment in rats.

Authors:  Dalel Askri; Souhir Ouni; Said Galai; Josiane Arnaud; Benoit Chovelon; Sylvia G Lehmann; Nathalie Sturm; Mohsen Sakly; Michel Sève; Salem Amara
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-05       Impact factor: 4.223

4.  Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect.

Authors:  Xihui Gao; Jun Qian; Shuyan Zheng; Ying Xiong; Jiahao Man; Binxin Cao; Lu Wang; Shenghong Ju; Cong Li
Journal:  Pharm Res       Date:  2013-03-15       Impact factor: 4.200

5.  Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.

Authors:  Wojciech G Lesniak; Manoj K Mishra; Amar Jyoti; Bindu Balakrishnan; Fan Zhang; Elizabeth Nance; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2013-10-30       Impact factor: 4.939

6.  An in vitro Blood-brain Barrier Model to Study the Penetration of Nanoparticles.

Authors:  Sezin Aday; Wen Li; Jeffrey M Karp; Nitin Joshi
Journal:  Bio Protoc       Date:  2022-02-20

7.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

Review 8.  Dendrimer advances for the central nervous system delivery of therapeutics.

Authors:  Leyuan Xu; Hao Zhang; Yue Wu
Journal:  ACS Chem Neurosci       Date:  2013-12-05       Impact factor: 4.418

9.  Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor.

Authors:  Tapan Kumar Shaw; Dipika Mandal; Goutam Dey; Murari Mohan Pal; Paramita Paul; Samrat Chakraborty; Kazi Asraf Ali; Biswajit Mukherjee; Amal Kumar Bandyopadhyay; Mahitosh Mandal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.

Authors:  Ana Paula Perez; Cecilia Mundiña-Weilenmann; Eder Lilia Romero; Maria Jose Morilla
Journal:  Int J Nanomedicine       Date:  2012-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.